Examining the 340B Drug Pricing Program
House Committee on Energy and Commerce Subcommittee on Health
Ann Maxwell, Deputy Inspector General for Evaluation and Inspections, Office of Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services
Testimony Statement PDF, 506.4 KB